Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Authors :: Astrup, Arne
Carraro, Romina
Finer, N
Harper, A
Kunesova, M
Lean, M E J
Niskanen, L
Rasmussen, M F
Rissanen, A
Rössner, S
Savolainen, M J
Van Gaal, L
Astrup, Arne
Carraro, Romina
Finer, N
Harper, A
Kunesova, M
Lean, M E J
Niskanen, L
Rasmussen, M F
Rissanen, A
Rössner, S
Savolainen, M J
Van Gaal, L
Source :: Astrup , A , Carraro , R , Finer , N , Harper , A , Kunesova , M , Lean , M E J , Niskanen , L , Rasmussen , M F , Rissanen , A , Rössner , S , Savolainen , M J & Van Gaal , L 2013 , ' Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide ' , International Journal of Obesity , vol. 37 , no. 2 , pp. 322 .
Publication Year :: 2013

Database :: OAIster
Journal :: Astrup , A , Carraro , R , Finer , N , Harper , A , Kunesova , M , Lean , M E J , Niskanen , L , Rasmussen , M F , Rissanen , A , Rössner , S , Savolainen , M J & Van Gaal , L 2013 , ' Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide ' , International Journal of Obesity , vol. 37 , no. 2 , pp. 322 .
Notes :: English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1322629212
Document Type :: Electronic Resource

Tools